Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.

This aptamer was selected by scientists at Base Pair Biotechnologies using proprietary methods and epirubicin as a target.

Epirubicin Aptamer Ordering Page

Epirubicin Aptamer Data Sheet